Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02479828
• Date of registration: 10/06/2015
• Prospective Registration: No
• Primary sponsor: Asklepieion Voulas General Hospital
• Public title: Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients
• Scientific title: The Effect of Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients
• Date of first enrolment: June 2015
• Target sample size: 198
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02479828
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
• Phase: N/A

Countries of recruitment

Greece

Contacts

• Name: MARIA DIAKOMI
• Affiliation: Asklepieion General Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- ASA I-III (American Society of Anesthesiologists classification)

- intertrochanteric fractures

- fractures of femoral neck

Exclusion Criteria:

- existing pain in hip Joint to be operated

- cognitive or mental disorder

- administration of analgesic drugs prior surgery

- contraindications of spinal anesthesia

- refusal to participate in the study



Age minimum: 18 Years
Age maximum: 90 Years
Gender: All

Health Condition(s) or Problem(s) studied

Chronic Hip Pain

Intervention(s)

Drug: Placebo

Drug: Fascia iliaca compartment block

Device: ultrasound

Drug: Ropivacaine

Primary Outcome(s)

Acute postsurgical pain after hip fracture surgery [Time Frame: 48 hours]

Chronic postsurgical pain after hip fracture surgery [Time Frame: 6 months]

Secondary ID(s)

7533

Source(s) of Monetary Support

Please refer to primary and secondary sponsors